Open Payments

CHILDRENS MERCY HOSPITAL

Type
Teaching hospital
Where
KANSAS CITY, MO
Medicare CCN
263302
Received
$3,006,610 in 465 records, 2019 ($115,255 general, $2,891,354 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2019General payment43$115,255
2019Research payment422$2,891,354

By company

CompanyRecordsAmountYears
BioFire Diagnostics, LLC63$786,0802019
JAZZ PHARMACEUTICALS INC.5$382,7662019
VERTEX PHARMACEUTICALS INCORPORATED15$285,3002019
Amgen Inc.22$250,7112019
Edwards Lifesciences Corporation30$180,2152019
Merck Sharp & Dohme LLC27$153,3732019
Astellas Pharma Global Development10$117,2352019
Purdue Pharma L.P.5$110,5002019
Cepheid1$82,6002019
Becton, Dickinson and Company2$69,8602019
Baxter Healthcare1$68,0002019
Gilead Sciences, Inc.36$59,6822019
Genentech, Inc.11$48,0612019
Mallinckrodt Enterprises LLC7$44,2692019
Shire North American Group Inc24$33,5242019
PFIZER INC.22$32,5252019
E.R. Squibb & Sons, L.L.C.6$26,1832019
Eisai Inc.15$24,0832019
Novartis Pharmaceuticals Corporation7$23,1562019
Allergan, Inc.20$22,5742019
Novo Nordisk AS17$21,2312019
SANOFI PASTEUR INC.3$19,7852019
Eli Lilly and Company5$18,4142019
ABBVIE INC.4$17,2872019
Alexion Pharmaceuticals, Inc.9$12,7652019
SANOFI US SERVICES INC.3$10,5002019
Travere Therapeutics, Inc.14$9,3702019
Incyte Corporation7$9,1202019
New York Blood Center, Inc.1$8,3102019
BioMarin Pharmaceutical Inc.5$7,4002019
GENZYME CORPORATION8$5,9502019
Bayer Healthcare Pharmaceuticals Inc.1$5,7152019
AMAG Pharmaceuticals, Inc.3$5,4682019
Horizon Therapeutics plc1$4,5562019
Abbott Laboratories4$4,3002019
Celgene Corporation1$3,4712019
SOBI, INC3$3,0002019
Ipsen Biopharmaceuticals, Inc1$3,0002019
Barco, Inc.2$2,8662019
Vifor Fresenius Medical Care Renal Pharma Ltd.2$2,8612019
Medtronic MiniMed, Inc.1$2,7502019
Grifols Therapeutics LLC2$2,3002019
United Therapeutics Corporation4$2,2252019
Saol Therapeutics Inc.1$2,0002019
Astellas US Technologies6$1,8922019
Janssen Research & Development, LLC1$1,7762019
AstraZeneca UK Limited2$1,6742019
SWEDISH ORPHAN BIOVITRUM AB2$1,6502019
GE HEALTHCARE1$1,5002019
Daiichi Sankyo Inc.1$1,5002019

By nature of payment

NatureRecordsAmount
Research payment422$2,891,354
Education4$69,306
Space rental or facility fees (teaching hospital only)32$33,130
Compensation for services other than consulting, including serving as faculty or as a speaker at a v1$8,310
Gift3$3,717
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing1$500
Consulting Fee1$150
Food and Beverage1$141

Records

DateCompanyAmountNatureFormProductStudyYear
2019-12-31BioFire Diagnostics, LLC$40,500Research paymentIn-kind items and servicesFilmArray System Device, Clinical DiagnosticsFilmArray GI Swab Pivotal Study2019
2019-12-31Allergan, Inc.$495Research paymentCash or cash equivalentLINZESS Drug, GASTROENTEROLOGYA MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, SAFETY AND EFFIACY STUDY OF A RANGE OF LINA2019
2019-12-31Allergan, Inc.$124Research paymentCash or cash equivalentBOTOX COSMETIC BiologicalBOTOX Treatment in Pediatric Lower Limb Spasticity Open-label Study2019
2019-12-31AstraZeneca UK Limited$74Research paymentIn-kind items and servicesBYDUREON Drug, Cardiovascular and MetabolismA Phase 3 Double Blind Placebo Controlled Randomized Multi Center Study To Assess the Safety and Efficacy of Exenatide O2019
2019-12-30BioFire Diagnostics, LLC$14,381Research paymentCash or cash equivalentFilmArray System Device, Clinical DiagnosticsFilmArray GI Swab Pivotal Study2019
2019-12-30BioFire Diagnostics, LLC$1,429Research paymentIn-kind items and servicesSpotFire System Device, Clinical DiagnosticsSpotFire RST Pivotal Study2019
2019-12-25Amgen Inc.$1,800Research paymentCash or cash equivalentAimovig Biological, NeurosciencePhase P3 Pediatric Study (EM)2019
2019-12-25Amgen Inc.$1,800Research paymentCash or cash equivalentAimovig Biological, NeurosciencePh3 Pediatric CM Study2019
2019-12-24Amgen Inc.$5,038Research paymentCash or cash equivalentParsabiv Biological, NephrologyPediatric Multi-Dose2019
2019-12-23PFIZER INC.$2,112Research paymentCash or cash equivalentA PHASE 3 MULTICENTER RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PARALLELGROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY O2019
2019-12-21Amgen Inc.$4,809Research paymentCash or cash equivalentAimovig Biological, NeuroscienceP1b study in children and adolescents with migraine2019
2019-12-21PFIZER INC.$249Research paymentCash or cash equivalentPREVNAR - 13 Biological, VACCINESA PHASE 2 RANDOMIZED OPENLABEL TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE V2019
2019-12-20Gilead Sciences, Inc.$718Research paymentCash or cash equivalentVemlidy Drug, HBVA Phase 2/3 Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Ala2019
2019-12-19Novo Nordisk AS$6,000Research paymentCash or cash equivalentSogroya Biological, Growth HormoneNN8640-42632019
2019-12-19Novo Nordisk AS$2,500Research paymentCash or cash equivalentSogroya Biological, Growth HormoneNN8640-42632019
2019-12-19Novo Nordisk AS$1,000Research paymentCash or cash equivalentSogroya Biological, Growth HormoneNN8640-42632019
2019-12-18Gilead Sciences, Inc.$1,284Research paymentCash or cash equivalentEpclusa Drug, HCVA Phase 2, Open-Label, Multicenter, Multi-cohort Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir 2019
2019-12-18Gilead Sciences, Inc.$1,156Research paymentCash or cash equivalentVemlidy Drug, HBVA Phase 2/3 Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Ala2019
2019-12-18Travere Therapeutics, Inc.$715Research paymentCash or cash equivalent(810) Chenodal Drug, Hepatology018CTXX150012019
2019-12-18Travere Therapeutics, Inc.$715Research paymentCash or cash equivalent(810) Chenodal Drug, Hepatology018CTXX150012019
2019-12-17Mallinckrodt Enterprises LLC$18,469Research paymentCash or cash equivalentINOMAX Drug, CRITICAL CAREREGISTRY EVALUATING PREMATURE AND TERM-NEAR-TERM NEONATES WITH PULMONARY HYPERTENSION RECEIVING INHALED NITRIC OXIDE2019
2019-12-13Merck Sharp & Dohme LLC$25,556Research paymentCash or cash equivalentPRIMAXIN Drug, INFECTIOUS DISEASEComparative In Vitro Activity of Imipenem-Relebactam against Pediatric Drug-Resistant Gram Negative Isolates from three 2019
2019-12-12Astellas Pharma Global Development$9,412Research paymentCash or cash equivalentCRESEMBA Drug, INFECTIOUS DISEASESA Phase 2, Open-Label, Non-Comparative, Multicenter Study to Evaluate the Safety and Tolerability, Efficacy and Pharmaco2019
2019-12-12Astellas Pharma Global Development$200Research paymentCash or cash equivalentCRESEMBA Drug, INFECTIOUS DISEASESA Phase 2, Open-Label, Non-Comparative, Multicenter Study to Evaluate the Safety and Tolerability, Efficacy and Pharmaco2019
2019-12-12BioMarin Pharmaceutical Inc.$200Research paymentCash or cash equivalentNaglazyme Biological, MPS VIMPS VI Clinical Surveillance Program (CSP)2019
2019-12-05Genentech, Inc.$3,797Research paymentCash or cash equivalentNon-Covered Product Drug, NoneCONFIRMATORY STUDY2019
2019-12-05PFIZER INC.$961Research paymentCash or cash equivalentPREVNAR - 13 Biological, VACCINESA PHASE 2 RANDOMIZED OPENLABEL TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE V2019
2019-12-05Merck Sharp & Dohme LLC$500Research paymentCash or cash equivalentMK-1654 Drug, INFECTIOUS DISEASEA Double-blind, Randomized, Placebo-controlled, Single Ascending Dose Trial to Evaluate the Safety, Tolerability, and Ph2019
2019-12-03Shire North American Group Inc$881Research paymentCash or cash equivalentGATTEX Drug, INTERNAL MEDICINEA RETROSPECTIVE AND PROSPECTIVE, OPEN LABEL, LONG-TERM SAFETY AND EFFICACY STUDY OF TEDUGLUTIDE IN PEDIATRIC PATIENTS WI2019
2019-11-30JAZZ PHARMACEUTICALS INC.$129,816Research paymentIn-kind items and servicesDEFITELIO Drug, HEMATOLOGYA PHASE 3, RANDOMIZED, ADAPTIVE STUDY COMPARING THE EFFICACY AND SAFETY OF DEFIBROTIDE VS BEST SUPPORTIVE CARE IN THE PR2019
2019-11-29Edwards Lifesciences Corporation$21,174Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesCOMPASSION S3 2015-012019
2019-11-29Edwards Lifesciences Corporation$17,603Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesALTERRA Early Feasibility 2016-042019
2019-11-27Amgen Inc.$16,250Research paymentCash or cash equivalentAimovig Biological, NeurosciencePhase P3 Pediatric Study (EM)2019
2019-11-27Amgen Inc.$14,350Research paymentCash or cash equivalentAimovig Biological, NeurosciencePh3 Pediatric CM Study2019
2019-11-27Shire North American Group Inc$719Research paymentCash or cash equivalentGATTEX Drug, INTERNAL MEDICINEA RETROSPECTIVE AND PROSPECTIVE, OPEN LABEL, LONG-TERM SAFETY AND EFFICACY STUDY OF TEDUGLUTIDE IN PEDIATRIC PATIENTS WI2019
2019-11-27PFIZER INC.$500Research paymentCash or cash equivalentA PHASE 3 MULTICENTER RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PARALLELGROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY O2019
2019-11-26BioFire Diagnostics, LLC$6,000Research paymentIn-kind items and servicesSpotFire System Device, Clinical DiagnosticsSpotFire RST Pivotal Study2019
2019-11-25Genentech, Inc.$75Research paymentCash or cash equivalentPegasys Biological, Virology & Specialty CarePEG LAMIVUDINE ENTECAVIR TX IN CHILDREN WITH CHRONIC HBV2019
2019-11-23PFIZER INC.$822Research paymentCash or cash equivalentPREVNAR - 13 Biological, VACCINESA PHASE 2 RANDOMIZED OPENLABEL TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE V2019
2019-11-21Allergan, Inc.$7,217Research paymentCash or cash equivalentDALVANCE Drug, ANTI-INFECTIVEPHARMACOKINETICS OF A SINGLE-DOSE OF DALBAVANCIN IN PRETERM NEONATES TO INFANTS AGES 3 MONTHS WITH SUSPECTED OR CONFIRME2019
2019-11-21Edwards Lifesciences Corporation$850Research paymentCash or cash equivalentCOMPASSION Study 2006-092019
2019-11-21SWEDISH ORPHAN BIOVITRUM AB$94Research paymentCash or cash equivalentKINERET Drug, INFLAMMATIONSOBI.ANAKIN-3012019
2019-11-19Shire North American Group Inc$1,776Research paymentCash or cash equivalentGATTEX Drug, INTERNAL MEDICINEA RETROSPECTIVE AND PROSPECTIVE, OPEN LABEL, LONG-TERM SAFETY AND EFFICACY STUDY OF TEDUGLUTIDE IN PEDIATRIC PATIENTS WI2019
2019-11-19OXFORD GENE TECHNOLOGY INC$141Food and Beverage (6 payments)In-kind items and services2019
2019-11-18BioFire Diagnostics, LLC$9,306Research paymentIn-kind items and servicesFilmArray System Device, Clinical DiagnosticsFilmArray GI Swab Pivotal Study2019
2019-11-14Edwards Lifesciences Corporation$9,218Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesALTERRA Early Feasibility 2016-042019
2019-11-14BioFire Diagnostics, LLC$3,240Research paymentIn-kind items and servicesSpotFire System Device, Clinical DiagnosticsSpotFire RST Pivotal Study2019
2019-11-14Edwards Lifesciences Corporation$854Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesCOMPASSION S3 2015-012019
2019-11-14Edwards Lifesciences Corporation$425Research paymentCash or cash equivalentCOMPASSION Study 2006-092019
2019-11-13Gilead Sciences, Inc.$510Research paymentCash or cash equivalentSovaldi Drug, HCVA Long Term Follow-up Registry for Pediatric Subjects Who Received Treatment in Gilead-Sponsored Chronic Hepatitis C Inf2019
2019-11-12Amgen Inc.$777Research paymentIn-kind items and servicesParsabiv Biological, NephrologyAMG 416 Pediatric2019
2019-11-09BioFire Diagnostics, LLC$10,555Research paymentCash or cash equivalentFilmArray System Device, Clinical DiagnosticsFilmArray GI Swab Pivotal Study2019
2019-11-08BioFire Diagnostics, LLC$19,195Research paymentCash or cash equivalentSpotFire System Device, Clinical DiagnosticsFilmArray 804 Pilot Study2019
2019-11-07BioFire Diagnostics, LLC$40,500Research paymentIn-kind items and servicesSpotFire System Device, Clinical DiagnosticsFilmArray 804 Pilot Study2019
2019-11-07Merck Sharp & Dohme LLC$450Research paymentCash or cash equivalentMK-1654 Drug, INFECTIOUS DISEASEA Double-blind, Randomized, Placebo-controlled, Single Ascending Dose Trial to Evaluate the Safety, Tolerability, and Ph2019
2019-11-07BioFire Diagnostics, LLC$40Research paymentCash or cash equivalentFilmArray System Device, Clinical DiagnosticsFilmArray GI Swab Pivotal Study2019
2019-11-04Alexion Pharmaceuticals, Inc.$863Research paymentCash or cash equivalentStrensiq Drug, EndocrinologyAn Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia HPP2019
2019-11-04Alexion Pharmaceuticals, Inc.$863Research paymentCash or cash equivalentStrensiq Drug, EndocrinologyAn Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia HPP2019
2019-11-04Alexion Pharmaceuticals, Inc.$863Research paymentCash or cash equivalentStrensiq Drug, EndocrinologyAn Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia HPP2019
2019-11-04Alexion Pharmaceuticals, Inc.$863Research paymentCash or cash equivalentStrensiq Drug, EndocrinologyAn Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia HPP2019
2019-10-31BioFire Diagnostics, LLC$13,500Research paymentIn-kind items and servicesFilmArray System Device, Clinical DiagnosticsFilmArray GI Swab Pivotal Study2019
2019-10-29Shire North American Group Inc$411Research paymentCash or cash equivalentGATTEX Drug, INTERNAL MEDICINEA RETROSPECTIVE AND PROSPECTIVE, OPEN LABEL, LONG-TERM SAFETY AND EFFICACY STUDY OF TEDUGLUTIDE IN PEDIATRIC PATIENTS WI2019
2019-10-28BioFire Diagnostics, LLC$39,260Research paymentCash or cash equivalentSpotFire System Device, Clinical DiagnosticsFilmArray 804 Pilot Study2019
2019-10-28Merck Sharp & Dohme LLC$329Research paymentIn-kind items and servicesMK-1654 Drug, INFECTIOUS DISEASEA Double-blind, Randomized, Placebo-controlled, Single Ascending Dose Trial to Evaluate the Safety, Tolerability, and Ph2019
2019-10-24Amgen Inc.$20,630Research paymentCash or cash equivalentParsabiv Biological, NephrologyPediatric Multi-Dose2019
2019-10-24PFIZER INC.$961Research paymentCash or cash equivalentPREVNAR - 13 Biological, VACCINESA PHASE 2 RANDOMIZED OPENLABEL TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE V2019
2019-10-23Gilead Sciences, Inc.$1,612Research paymentCash or cash equivalentSovaldi Drug, HCVA Long Term Follow-up Registry for Pediatric Subjects Who Received Treatment in Gilead-Sponsored Chronic Hepatitis C Inf2019
2019-10-23Gilead Sciences, Inc.$996Research paymentCash or cash equivalentVemlidy Drug, HBVA Phase 2/3 Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Ala2019
2019-10-23Gilead Sciences, Inc.$958Research paymentCash or cash equivalentEpclusa Drug, HCVA Phase 2, Open-Label, Multicenter, Multi-cohort Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir 2019
2019-10-22Amgen Inc.$1,689Research paymentIn-kind items and servicesParsabiv Biological, NephrologyPediatric Multi-Dose2019
2019-10-21SWEDISH ORPHAN BIOVITRUM AB$1,556Research paymentCash or cash equivalentKINERET Drug, INFLAMMATIONSOBI.ANAKIN-3012019
2019-10-21Travere Therapeutics, Inc.$1,498Research paymentCash or cash equivalentDUET2019
2019-10-21Travere Therapeutics, Inc.$148Research paymentCash or cash equivalentDUET2019
2019-10-17Shire North American Group Inc$936Research paymentCash or cash equivalentGATTEX Drug, INTERNAL MEDICINEA RETROSPECTIVE AND PROSPECTIVE, OPEN LABEL, LONG-TERM SAFETY AND EFFICACY STUDY OF TEDUGLUTIDE IN PEDIATRIC PATIENTS WI2019
2019-10-15Allergan, Inc.$500Research paymentCash or cash equivalentLINZESS Drug, GASTROENTEROLOGYA MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, SAFETY AND EFFIACY STUDY OF A RANGE OF LINA2019
2019-10-14Travere Therapeutics, Inc.$200Research paymentCash or cash equivalent021FSGS160102019
2019-10-14BioFire Diagnostics, LLC$151Research paymentCash or cash equivalentFilmArray System Device, Clinical DiagnosticsFilmArray GI Swab Pivotal Study2019
2019-10-11BioFire Diagnostics, LLC$17,125Research paymentCash or cash equivalentFilmArray System Device, Clinical DiagnosticsFilmArray GI Swab Pivotal Study2019
2019-10-10SANOFI PASTEUR INC.$12,880Research paymentCash or cash equivalentYELLOW FEVER DrugSTA00011 Stamaril Yellow Fever2019
2019-10-10SANOFI US SERVICES INC.$4,500Research paymentCash or cash equivalentDUPIXENT Drug, IMMUNOLOGYEvaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients Whose Disease is Not Adequately Controlled With Topi2019
2019-10-10Shire North American Group Inc$2,157Research paymentCash or cash equivalentGATTEX Drug, INTERNAL MEDICINEA RETROSPECTIVE AND PROSPECTIVE, OPEN LABEL, LONG-TERM SAFETY AND EFFICACY STUDY OF TEDUGLUTIDE IN PEDIATRIC PATIENTS WI2019
2019-10-10SANOFI US SERVICES INC.$1,750Research paymentCash or cash equivalentDUPIXENT Drug, IMMUNOLOGYEvaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients Whose Disease is Not Adequately Controlled With Topi2019
2019-10-10Grifols Therapeutics LLC$1,000Research paymentCash or cash equivalentAlphanate Biological, HematologyA Multicenter Phase 2 Open-Label, Single-Arm, Prospective, Interventional Study of PlasmaDerived Factor VIIIVWF Alphanat2019
2019-10-10Allergan, Inc.$300Research paymentCash or cash equivalentDALVANCE Drug, ANTI-INFECTIVEPHARMACOKINETICS OF A SINGLE-DOSE OF DALBAVANCIN IN PRETERM NEONATES TO INFANTS AGES 3 MONTHS WITH SUSPECTED OR CONFIRME2019
2019-10-08BioFire Diagnostics, LLC$1,663Research paymentIn-kind items and servicesSpotFire System Device, Clinical DiagnosticsFilmArray 804 Pilot Study2019
2019-10-08Incyte Corporation$74Research paymentCash or cash equivalentA Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr2019
2019-10-08Incyte Corporation$21Research paymentCash or cash equivalentA Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr2019
2019-10-08Incyte Corporation$12Research paymentCash or cash equivalentA Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr2019
2019-10-08Incyte Corporation$12Research paymentCash or cash equivalentA Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr2019
2019-10-08BioFire Diagnostics, LLC$3Research paymentCash or cash equivalentFilmArray System Device, Clinical DiagnosticsFilmArray GI Swab Pivotal Study2019
2019-10-05Astellas US Technologies$315Research paymentIn-kind items and servicesCRESEMBA Drug, INFECTIOUS DISEASESA Phase 2, Open-Label, Non-Comparative, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Isavu2019
2019-10-05Astellas US Technologies$315Research paymentIn-kind items and servicesCRESEMBA Drug, INFECTIOUS DISEASESA Phase 2, Open-Label, Non-Comparative, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Isavu2019
2019-10-05Astellas US Technologies$315Research paymentIn-kind items and servicesCRESEMBA Drug, INFECTIOUS DISEASESA Phase 2, Open-Label, Non-Comparative, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Isavu2019
2019-10-05Astellas US Technologies$315Research paymentIn-kind items and servicesCRESEMBA Drug, INFECTIOUS DISEASESA Phase 2, Open-Label, Non-Comparative, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Isavu2019
2019-10-05Astellas US Technologies$315Research paymentIn-kind items and servicesCRESEMBA Drug, INFECTIOUS DISEASESA Phase 2, Open-Label, Non-Comparative, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Isavu2019
2019-10-05Astellas US Technologies$315Research paymentIn-kind items and servicesCRESEMBA Drug, INFECTIOUS DISEASESA Phase 2, Open-Label, Non-Comparative, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Isavu2019
2019-10-04Mallinckrodt Enterprises LLC$10,294Research paymentCash or cash equivalentINOMAX Drug, CRITICAL CAREREGISTRY EVALUATING PREMATURE AND TERM-NEAR-TERM NEONATES WITH PULMONARY HYPERTENSION RECEIVING INHALED NITRIC OXIDE2019
2019-10-04Philips North America LLC$1,000Research paymentCash or cash equivalentUS Und Device, Cardiology/Vascular DiseasesVM 5.02019
2019-10-04GENZYME CORPORATION$700Space rental or facility fees (teaching hospital only)Cash or cash equivalentCERDELGA Drug, RARE DISEASE GENETICS2019
2019-10-04Novartis Pharmaceuticals Corporation$600Space rental or facility fees (teaching hospital only)Cash or cash equivalentKYMRIAH Biological, ONCOLOGY2019
2019-10-03Alexion Pharmaceuticals, Inc.$600Space rental or facility fees (teaching hospital only)Cash or cash equivalentKanuma Drug, Immunology2019
2019-10-02Genentech, Inc.$7,388Research paymentCash or cash equivalentPegasys Biological, Virology & Specialty CarePEG LAMIVUDINE ENTECAVIR TX IN CHILDREN WITH CHRONIC HBV2019
2019-09-30BioFire Diagnostics, LLC$39,000Research paymentIn-kind items and servicesFilmArray System Device, Clinical DiagnosticsFilmArray GI Swab Pivotal Study2019
2019-09-30BioFire Diagnostics, LLC$1,429Research paymentIn-kind items and servicesSpotFire System Device, Clinical DiagnosticsFilmArray 804 Pilot Study2019
2019-09-30BioFire Diagnostics, LLC$1,429Research paymentIn-kind items and servicesSpotFire System Device, Clinical DiagnosticsFilmArray 804 Pilot Study2019
2019-09-30BioFire Diagnostics, LLC$232Research paymentIn-kind items and servicesFilmArray System Device, Clinical DiagnosticsFilmArray GI Swab Pivotal Study2019
2019-09-30Merck Sharp & Dohme LLC$1Research paymentIn-kind items and servicesMK-1654 Drug, INFECTIOUS DISEASEA Double-blind, Randomized, Placebo-controlled, Single Ascending Dose Trial to Evaluate the Safety, Tolerability, and Ph2019
2019-09-26GlaxoSmithKline, LLC.$1,500Space rental or facility fees (teaching hospital only)Cash or cash equivalentMENVEO Biological, VACCINES2019
2019-09-26Genentech, Inc.$828Research paymentCash or cash equivalentPegasys Biological, Virology & Specialty CarePEG LAMIVUDINE ENTECAVIR TX IN CHILDREN WITH CHRONIC HBV2019
2019-09-24PFIZER INC.$1,339Research paymentCash or cash equivalentPREVNAR - 13 Biological, VACCINESA PHASE 2 RANDOMIZED OPENLABEL TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE V2019
2019-09-19Edwards Lifesciences Corporation$22,703Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesALTERRA Early Feasibility 2016-042019
2019-09-19Edwards Lifesciences Corporation$569Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesCOMPASSION S3 2015-012019
2019-09-19Mallinckrodt Enterprises LLC$300Research paymentCash or cash equivalentINOMAX Drug, CRITICAL CAREREGISTRY EVALUATING PREMATURE AND TERM-NEAR-TERM NEONATES WITH PULMONARY HYPERTENSION RECEIVING INHALED NITRIC OXIDE2019
2019-09-18Astellas Pharma Global Development$58,865Research paymentCash or cash equivalentCRESEMBA Drug, INFECTIOUS DISEASESObservational Disease Registry of Patients Treated With Systemic Mold-Active Triazoles2019
2019-09-18BioFire Diagnostics, LLC$11,740Research paymentCash or cash equivalentFilmArray System Device, Clinical DiagnosticsFilmArray GI Swab Pivotal Study2019
2019-09-18Gilead Sciences, Inc.$1,802Research paymentCash or cash equivalentVemlidy Drug, HBVA Phase 2/3 Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Ala2019
2019-09-18SOBI, INC$1,500Space rental or facility fees (teaching hospital only)Cash or cash equivalentSYNAGIS Drug, Immunology2019
2019-09-18SANOFI PASTEUR INC.$1,500Space rental or facility fees (teaching hospital only)Cash or cash equivalentPENTACEL Drug, VACCINES2019
2019-09-17Shire North American Group Inc$2,092Research paymentCash or cash equivalentGATTEX Drug, INTERNAL MEDICINEA RETROSPECTIVE AND PROSPECTIVE, OPEN LABEL, LONG-TERM SAFETY AND EFFICACY STUDY OF TEDUGLUTIDE IN PEDIATRIC PATIENTS WI2019
2019-09-17Shire North American Group Inc$1,676Research paymentCash or cash equivalentGATTEX Drug, INTERNAL MEDICINEA RETROSPECTIVE AND PROSPECTIVE, OPEN LABEL, LONG-TERM SAFETY AND EFFICACY STUDY OF TEDUGLUTIDE IN PEDIATRIC PATIENTS WI2019
2019-09-16Genentech, Inc.$5,134Research paymentCash or cash equivalentNon-Covered Product Drug, NoneCONFIRMATORY STUDY2019
2019-09-12PFIZER INC.$1,000Research paymentCash or cash equivalentA PHASE 3 MULTICENTER RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PARALLELGROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY O2019
2019-09-12Allergan, Inc.$500EducationCash or cash equivalent2019
2019-09-11VERTEX PHARMACEUTICALS INCORPORATED$18,511Research paymentCash or cash equivalentA Study Evaluating the Long-term Safety of VX-445 Combination Therapy2019
2019-09-11BioFire Diagnostics, LLC$8,499Research paymentCash or cash equivalentFilmArray System Device, Clinical DiagnosticsFilmArray CSI Pilot Study2019
2019-09-11Edwards Lifesciences Corporation$8,423Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesALTERRA Early Feasibility 2016-042019
2019-09-11BioMarin Pharmaceutical Inc.$3,800Research paymentCash or cash equivalentKuvan Drug, PKUPKU Demographics, Outcomes, and Safety Registry2019
2019-09-11Edwards Lifesciences Corporation$3,324Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesCOMPASSION S3 2015-012019
2019-09-10Shire North American Group Inc$2,723Research paymentCash or cash equivalentGATTEX Drug, INTERNAL MEDICINEA RETROSPECTIVE AND PROSPECTIVE, OPEN LABEL, LONG-TERM SAFETY AND EFFICACY STUDY OF TEDUGLUTIDE IN PEDIATRIC PATIENTS WI2019
2019-09-10Shire North American Group Inc$1,797Research paymentCash or cash equivalentGATTEX Drug, INTERNAL MEDICINEA RETROSPECTIVE AND PROSPECTIVE, OPEN LABEL, LONG-TERM SAFETY AND EFFICACY STUDY OF TEDUGLUTIDE IN PEDIATRIC PATIENTS WI2019
2019-09-10Shire North American Group Inc$1,332Research paymentCash or cash equivalentGATTEX Drug, INTERNAL MEDICINEA RETROSPECTIVE AND PROSPECTIVE, OPEN LABEL, LONG-TERM SAFETY AND EFFICACY STUDY OF TEDUGLUTIDE IN PEDIATRIC PATIENTS WI2019
2019-09-10Allergan, Inc.$931Research paymentCash or cash equivalentLINZESS Drug, GASTROENTEROLOGYA Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of a Range of Lin2019
2019-09-10Shire North American Group Inc$855Research paymentCash or cash equivalentGATTEX Drug, INTERNAL MEDICINEA RETROSPECTIVE AND PROSPECTIVE, OPEN LABEL, LONG-TERM SAFETY AND EFFICACY STUDY OF TEDUGLUTIDE IN PEDIATRIC PATIENTS WI2019
2019-09-10Shire North American Group Inc$805Research paymentCash or cash equivalentGATTEX Drug, INTERNAL MEDICINEA RETROSPECTIVE AND PROSPECTIVE, OPEN LABEL, LONG-TERM SAFETY AND EFFICACY STUDY OF TEDUGLUTIDE IN PEDIATRIC PATIENTS WI2019
2019-09-09Merck Sharp & Dohme LLC$25,556Research paymentCash or cash equivalentPRIMAXIN Drug, INFECTIOUS DISEASEComparative In Vitro Activity of Imipenem-Relebactam against Pediatric Drug-Resistant Gram Negative Isolates from three 2019
2019-09-09BioFire Diagnostics, LLC$9,300Research paymentIn-kind items and servicesFilmArray System Device, Clinical DiagnosticsFilmArray GI Swab Pivotal Study2019
2019-09-09Gilead Sciences, Inc.$15Research paymentCash or cash equivalentSovaldi Drug, HCVA Long Term Follow-up Registry for Pediatric Subjects Who Received Treatment in Gilead-Sponsored Chronic Hepatitis C Inf2019
2019-09-05JAZZ PHARMACEUTICALS INC.$237,499Research paymentCash or cash equivalentDEFITELIO Drug, HEMATOLOGYUSING ULTRASOUND ELASTOGRAPHY TO PREDICT DEVELOPMENT OF HEPATIC VENO-OCCLUSIVE DISEASE/SUNISOIDAL OBSTRUCTION SYNDROME.2019
2019-09-05Alexion Pharmaceuticals, Inc.$1,500Research paymentCash or cash equivalentStrensiq Drug, EndocrinologyAn Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia HPP2019
2019-09-05SOBI, INC$1,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentSYNAGIS Drug, Immunology2019
2019-09-05BioFire Diagnostics, LLC$181Research paymentIn-kind items and servicesSpotFire System Device, Clinical DiagnosticsFilmArray 804 Pilot Study2019
2019-09-04Novo Nordisk AS$10,000Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-42632019
2019-09-04Abbott Laboratories$1,500Space rental or facility fees (teaching hospital only)Cash or cash equivalentCardiovascular- Research only Device, Cardiac Arrhythmias and Heart Failure2019
2019-09-04Abbott Laboratories$1,500Space rental or facility fees (teaching hospital only)Cash or cash equivalentCardiovascular- Research only Device, Cardiac Arrhythmias and Heart Failure2019
2019-09-04Novo Nordisk AS$831Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-42632019
2019-09-04Novo Nordisk AS$250Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-42632019
2019-09-04Novo Nordisk AS$250Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-42632019
2019-09-04Novo Nordisk AS$150Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-42632019
2019-09-04Novo Nordisk AS$22Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-42632019
2019-09-04Novo Nordisk AS$10Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-42632019
2019-09-04Novo Nordisk AS$9Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-42632019
2019-09-04Novo Nordisk AS$6Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-42632019
2019-09-04Novo Nordisk AS$3Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-42632019
2019-09-04Novo Nordisk AS$1Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-42632019
2019-09-04Novo Nordisk AS$1Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-42632019
2019-09-03GE HEALTHCARE$1,500Space rental or facility fees (teaching hospital only)Cash or cash equivalent Device, ULTRASOUND2019
2019-08-30PFIZER INC.$1,695Research paymentCash or cash equivalentPREVNAR - 13 Biological, VACCINESA PHASE 2 RANDOMIZED OPENLABEL TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE V2019
2019-08-29Incyte Corporation$3,000Research paymentCash or cash equivalentA Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr2019
2019-08-29Incyte Corporation$2,000Research paymentCash or cash equivalentA Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr2019
2019-08-29BioFire Diagnostics, LLC$67Research paymentIn-kind items and servicesFilmArray System Device, Clinical DiagnosticsFilmArray GI Swab Pivotal Study2019
2019-08-28United Therapeutics Corporation$400Research paymentCash or cash equivalentREMODULIN Drug, PAHINTRAVENOUS REMODULIN TREPROSTINIL AS ADD-ON THERAPY FOR THE TREATMENT OF PERSISTENT PULMONARY HYPERTENSION OF THE NEWBO2019
2019-08-28Novo Nordisk AS$117Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-42632019
2019-08-28Novo Nordisk AS$75Research paymentIn-kind items and servicesSogroya Biological, Growth HormoneNN8640-42632019
2019-08-27Amgen Inc.$5,174Research paymentIn-kind items and servicesAimovig Biological, NeurosciencePhase P3 Pediatric Study (EM)2019
2019-08-27BioFire Diagnostics, LLC$4,650Research paymentIn-kind items and servicesFilmArray System Device, Clinical DiagnosticsFilmArray GI Swab Pivotal Study2019
2019-08-27BioFire Diagnostics, LLC$1,470Research paymentIn-kind items and servicesSpotFire System Device, Clinical DiagnosticsFilmArray 804 Pilot Study2019
2019-08-26BioFire Diagnostics, LLC$288Research paymentIn-kind items and servicesFilmArray System Device, Clinical DiagnosticsFilmArray GI Swab Pivotal Study2019
2019-08-26Gilead Sciences, Inc.$15Research paymentCash or cash equivalentSovaldi Drug, HCVA Long Term Follow-up Registry for Pediatric Subjects Who Received Treatment in Gilead-Sponsored Chronic Hepatitis C Inf2019
2019-08-23Edwards Lifesciences Corporation$5,874Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesCOMPASSION S3 2015-012019
2019-08-23Edwards Lifesciences Corporation$3,833Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesALTERRA Early Feasibility 2016-042019
2019-08-21Gilead Sciences, Inc.$903Research paymentCash or cash equivalentEpclusa Drug, HCVA Phase 2, Open-Label, Multicenter, Multi-cohort Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir 2019
2019-08-21Oticon Medical, LLC$306EducationCash or cash equivalentPONTO BONE ANCHORED HEARING SYSTEM Device, Medical Device2019
2019-08-21AMAG Pharmaceuticals, Inc.$300Research paymentCash or cash equivalentFERAHEME Drug, PARENTERAL IRON REPLACEMENTA PHASE 3, RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE SAFETY COMPARED TO IRON SUCROSE, EFFICACY AND PHARM2019
2019-08-19BioFire Diagnostics, LLC$22,520Research paymentCash or cash equivalentSpotFire System Device, Clinical DiagnosticsFilmArray 804 Pilot Study2019
2019-08-19BioFire Diagnostics, LLC$1,429Research paymentIn-kind items and servicesSpotFire System Device, Clinical DiagnosticsFilmArray 804 Pilot Study2019
2019-08-16ABBVIE INC.$15,350Research paymentCash or cash equivalentLupron Depot Drug, EndocrinologyM16-9042019
2019-08-16BioFire Diagnostics, LLC$4,232Research paymentCash or cash equivalentFilmArray System Device, Clinical DiagnosticsFilmArray GI Swab Pivotal Study2019
2019-08-14BioFire Diagnostics, LLC$22,800Research paymentIn-kind items and servicesSpotFire System Device, Clinical DiagnosticsFilmArray 804 Pilot Study2019
2019-08-14BioFire Diagnostics, LLC$9,411Research paymentIn-kind items and servicesFilmArray System Device, Clinical DiagnosticsFilmArray GI Swab Pivotal Study2019
2019-08-14United Therapeutics Corporation$500Research paymentCash or cash equivalentREMODULIN Drug, PAHINTRAVENOUS REMODULIN TREPROSTINIL AS ADD-ON THERAPY FOR THE TREATMENT OF PERSISTENT PULMONARY HYPERTENSION OF THE NEWBO2019
2019-08-13Eisai Inc.$1,255Research paymentCash or cash equivalentFycompa Drug, NeurologyA Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial With an Open-Label Extension Phase of Perampanel as Ad2019
2019-08-13BioFire Diagnostics, LLC$29Research paymentIn-kind items and servicesSpotFire System Device, Clinical DiagnosticsFilmArray 804 Pilot Study2019
2019-08-12Gilead Sciences, Inc.$1,436Research paymentCash or cash equivalentVemlidy Drug, HBVA Phase 2/3 Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Ala2019
2019-08-12Gilead Sciences, Inc.$1,300Research paymentCash or cash equivalentVemlidy Drug, HBVA Phase 2/3 Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Ala2019
2019-08-12ZOLL Medical Corporation$500Space rental or facility fees (teaching hospital only)Cash or cash equivalent Device, DEFIBRILLATOR2019
2019-08-12BioFire Diagnostics, LLC$15Research paymentIn-kind items and servicesSpotFire System Device, Clinical DiagnosticsFilmArray 804 Pilot Study2019
2019-08-09PFIZER INC.$1,500Space rental or facility fees (teaching hospital only)Cash or cash equivalentEUCRISA Drug, DERMATOLOGY2019
2019-08-08Amgen Inc.$261Research paymentIn-kind items and servicesAimovig Biological, NeurosciencePhase P3 Pediatric Study (EM)2019
2019-08-08Amgen Inc.$138Research paymentIn-kind items and servicesAimovig Biological, NeurosciencePh3 Pediatric CM Study2019
2019-08-07Astellas Pharma Global Development$1,000Research paymentCash or cash equivalentCRESEMBA Drug, INFECTIOUS DISEASESA Phase 1, Open-label, Multicenter, Non-comparative Pharmacokinetics and Safety Study of Intravenous and Oral Isavuconaz2019
2019-08-06PFIZER INC.$961Research paymentCash or cash equivalentPREVNAR - 13 Biological, VACCINESA PHASE 2 RANDOMIZED OPENLABEL TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE V2019
2019-08-02Edwards Lifesciences Corporation$10,974Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesCOMPASSION S3 2015-012019
2019-08-02Edwards Lifesciences Corporation$7,383Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesALTERRA Early Feasibility 2016-042019
2019-08-01BioFire Diagnostics, LLC$39,587Research paymentCash or cash equivalentFilmArray System Device, Clinical DiagnosticsFilmArray CSI Pilot Study2019
2019-08-01Genentech, Inc.$815Research paymentCash or cash equivalentPegasys Biological, Virology & Specialty CarePEG LAMIVUDINE ENTECAVIR TX IN CHILDREN WITH CHRONIC HBV2019
2019-07-30Eisai Inc.$300Research paymentCash or cash equivalentFycompa Drug, NeurologyAn Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Rel2019
2019-07-29Purdue Pharma L.P.$10,200Research paymentCash or cash equivalentOXYCONTIN Drug, PAIN MANAGEMENTPMR 2923-2 study of OxyContin utilization among pediatric patients2019
2019-07-27Allergan, Inc.$500EducationCash or cash equivalent2019
2019-07-25Mylan Specialty L.P.$500Space rental or facility fees (teaching hospital only)Cash or cash equivalentTOBI Drug, Respiratory and Allergy2019
2019-07-23Genentech, Inc.$8,500Research paymentCash or cash equivalentHEMLIBRA Biological, HematologyEMICIZUMAB MINOR SURGERY2019

The latest 200 records of 465.

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Jackson CountyKansas City city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Kansas City, MO, county Jackson County, MO, state Missouri; placed by its city name.

MeasurePlace (city or town)
Kansas City, MO
County
Jackson County, MO
State
Missouri
Population B01003510,612719,9766,191,814
Population, 2020 census P1508,090717,2046,154,913
Median age B0100235.837.039.0
Under 18 B0100122.5%23.3%22.3%
65 and over B0100114.3%15.9%17.9%
Households B11001221,979306,7982,508,227
Foreign born B050028.6%6.6%4.5%
Median household income B19013$69,166$68,577$70,702
Median family income B19113$92,934$90,585$91,360
Per capita income B19301$41,393$39,559$39,695
Poverty rate B1700114.6%14.1%12.6%
Unemployment rate B230254.4%4.7%4.0%
Civilian labor force B23025279,828381,4333,120,639
Mean commute (minutes) B0801321.723.423.5
Bachelor's degree or higher B1500338.4%34.0%32.4%
Housing units B25001245,346336,2882,825,287
Owner-occupied B2500355.4%59.1%68.1%
Renters B2500344.6%40.9%31.9%
Median home value B25077$242,900$230,500$230,300
Median gross rent B25064$1,238$1,197$1,033
White, not Hispanic B0300254.0%59.3%76.3%
Black B0300225.2%22.0%10.9%
Hispanic or Latino B0300212.5%11.4%5.2%
Asian B030022.8%1.8%2.1%
American Indian and Alaska Native B030020.1%0.1%0.2%

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Kansas City, MO.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.